Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer

Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer

© 2014 Korean Breast Cancer Society. All rights reserved. Purpose: We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and compared to the stand...

Full description

Saved in:
Bibliographic Details
Main Authors: Jitawatanarat,P., O’connor,T.L., Kossoff,E.B., Levine,E.G., Chittawatanarat,K., Ngamphaiboon,N.
Format: Article
Published: Korean Breast Cancer Society 2015
Subjects:
Cancer Research
Oncology
Online Access:http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919832059&origin=inward
http://cmuir.cmu.ac.th/handle/6653943832/38356
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919832059&origin=inward
http://cmuir.cmu.ac.th/handle/6653943832/38356

Similar Items